This study represents first comprehensive analysis of plasma IgA glycosylation during active severe infections caused by SARS-CoV-2 or Influenza A, revealing lower sialylation and higher galactosylation of IgA1 O-glycans in patients with ARDS, regardless of the underlying cause of the disease. This evidence concerns the gene CD79A and acute respiratory distress syndrome.